When people with human immunodeficiency virus (HIV) develop high blood pressure, the type of medication chosen for their initial treatment may influence their risk of heart disease, stroke and heart failure, according to ...
Apr 5, 2021
0
3
Less than half the population of Africa are not receiving the health services they need, with vulnerable groups including gay and disabled people left behind, says a report.
Apr 1, 2021
0
5
Recent data reveals that gay men living with HIV report having supportive relationships with family, friends, or in informal relationships rather than with primary romantic partners, while gay men who are HIV negative report ...
Feb 17, 2021
0
0
Radiomics—the extraction of very detailed quantitative features from medical images—provides a refined understanding of how cocaine use and other risk factors affect the course of coronary artery disease, according to ...
Feb 16, 2021
0
5
According to 2018 data, one in five people in the United States probably carries a sexually transmitted infection, the U.S. Centers for Disease Control and Prevention says.
Jan 26, 2021
0
25
(HealthDay)—From 2010 to 2018, there was a 36.6 percent decrease in the rate of death among persons with diagnosed HIV (PWDH), according to a Vital Signs report published in the Nov. 20 issue of the U.S. Centers for Disease ...
Nov 20, 2020
0
1
Clinical trials are testing whether medications that treat human immunodeficiency virus (HIV) can also treat COVID-19, leading some patients with HIV to believe they might be protected against the coronavirus. But a researcher ...
Sep 30, 2020
0
2
The first person to be cured of HIV, Timothy Ray Brown—known as the "Berlin Patient"—has died after a battle with cancer, the International Aids Society (IAS) announced Wednesday.
Sep 30, 2020
0
4
Based on official figures—which may be somewhat under reported—COVID-19 has not been as devastating in South Africa as initially feared.
Sep 22, 2020
0
2
Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.
Sep 17, 2020
0
35
